Form 4: West Pharmaceutical Services Director Janet Haugen Reports Acquisition and Disposal of Common Stock

Director Janet Brutschea Haugen reports changes in beneficial ownership of West Pharmaceutical Services Inc. common stock, including acquisition of restricted stock units and disposal of shares.

Summary

• On May 6, 2025, Janet Brutschea Haugen, a director of West Pharmaceutical Services Inc., reported transactions involving the company's common stock.
• Haugen acquired 1,071 shares of common stock.
• These shares were acquired as restricted stock units that will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors.
• Haugen also disposed of 1,318.16 shares of common stock.
• Following these transactions, Haugen beneficially owns 1,071 shares of common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a standard Form 4 filing reporting changes in beneficial ownership. There is no indication of positive or negative sentiment.

Positives

• The acquisition of restricted stock units indicates continued alignment of the director's interests with the company's long-term performance.

Future Outlook

The restricted stock units will vest in full on the date of the next annual shareholder meeting.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.

Stakeholder Impact

• The transactions provide transparency to shareholders regarding the director's holdings and alignment with company interests.

Next Steps

• The restricted stock units will vest at the next annual shareholder meeting.

Key Dates

Keywords

Form 4, Beneficial Ownership, West Pharmaceutical Services, Director, Stock Transaction, Janet Haugen, WST, Restricted Stock Units